Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges

Abstract Introduction This study investigated the comparability of potential Alzheimer's disease (AD) biomarkers across blood fractions and assay platforms. Methods Nonfasting serum and plasma samples from 300 participants (150 AD patients and 150 controls) were analyzed. Proteomic markers were...

Full description

Bibliographic Details
Main Authors: Sid E. O'Bryant, Simone Lista, Robert A. Rissman, Melissa Edwards, Fan Zhang, James Hall, Henrik Zetterberg, Simon Lovestone, Veer Gupta, Neill Graff‐Radford, Ralph Martins, Andreas Jeromin, Stephen Waring, Esther Oh, Mitchel Kling, Laura D. Baker, Harald Hampel, ISTAART Blood Based Biomarker Professional Interest Area
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
Blood
Serum
Plasma
Biomarker discovery
Multiplex assay platform
Online Access:https://doi.org/10.1016/j.dadm.2015.12.003

Internet

https://doi.org/10.1016/j.dadm.2015.12.003

Similar Items